Home > PE Ratio > KILITCH DRUGS (INDIA)

KILITCH DRUGS (INDIA)
PE (Price/Earnings) Ratio

The Current P/E Ratio of KILITCH DRUGS (INDIA) is 44.18.

Share Price ₹351.2Apr 18,2024
Market Cap ₹565.4 Cr
Earnings-TTM₹12.8 CrTTM-Consolidated Results
Price/Earnings44.18xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for KILITCH DRUGS (INDIA)
Please provide your vote to see the results

Definition & Calculation of PE (Price/Earnings) ratio of KILITCH DRUGS (INDIA)

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of KILITCH DRUGS (INDIA) is calculated as :

Current Market Cap [ ₹565.4 Cr] as on Apr 18,2024

(/) Earnings [ ₹12.8 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 44.18x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for KILITCH DRUGS (INDIA) , the investors are currently willing to pay 44.18 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of KILITCH DRUGS (INDIA) !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of KILITCH DRUGS (INDIA) over the last five years.

Historical PE (Price/Earnings) ratio chart of KILITCH DRUGS (INDIA)


PE Ratio Performance Analysis for KILITCH DRUGS (INDIA)

- KILITCH DRUGS (INDIA) 's latest p/e ratio is 44.18x.

- KILITCH DRUGS (INDIA) 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 63.74x.

- KILITCH DRUGS (INDIA) 's operated at median p/e ratio of 35.47x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, KILITCH DRUGS (INDIA) 's p/e ratio peaked in Mar2020 at 148.95x.

- KILITCH DRUGS (INDIA) 's p/e ratio hit its five-year low in Mar2023 of 20.81x.


How does KILITCH DRUGS (INDIA) 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
KILITCH DRUGS (INDIA) 12.8044.18565.4
SUN PHARMACEUTICAL INDUSTRIES LTD8,998.6340.45364,015.0
CIPLA LTD3,744.0329.06108,809.0
DR REDDYS LABORATORIES LTD5,209.4019.0899,408.7
ZYDUS LIFESCIENCES LTD2,954.2031.8994,213.7
DIVIS LABORATORIES LTD1,382.9771.3698,684.0
MANKIND PHARMA LTD1,743.3055.0996,037.1
TORRENT PHARMACEUTICALS LTD1,494.0057.7186,219.0
LUPIN LTD1,809.7440.1372,621.1
AUROBINDO PHARMA LTD2,777.8923.5265,326.3
ABBOTT INDIA LTD1,145.5848.3355,366.4

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs KILITCH DRUGS (INDIA) 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 19.08x
Max industry PE 71.36x
Median industry PE 40.45x
Average industry PE 41.89x



You may also like the below Video Courses